生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Liothyronine represents an active thyroid hormone variant. It acts as a powerful agonist for the thyroid hormone receptors TRα and TRβ, exhibiting Ki values of 2.33 nM for both hTRα and hTRβ, respectively[1].[2].[3]. Produced in accordance with GMP guidelines, Liothyronine (Triiodothyronine) (GMP), also known as Liothyronine, functions effectively as a supportive reagent in cell therapy production. It serves as a strong agonist for the thyroid hormone receptors TRα and TRβ with Ki values of 2.33 nM for each, hTRα and hTRβ, respectively[1]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02133040 | - | Active, not recruiting | May 10, 2020 | Denmark ... 展开 >> Aarhus University Hospital Aarhus, Region Midtjylland, Denmark, 8000 收起 << | |
NCT02398344 | Stroke | Phase 1 Phase 2 | Completed | - | Brazil ... 展开 >> University of Nove de Julho São Paulo, Brazil 收起 << |
NCT02733497 | Hyperhidrosis | Not Applicable | Completed | - | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.54mL 0.31mL 0.15mL |
7.68mL 1.54mL 0.77mL |
15.36mL 3.07mL 1.54mL |
参考文献 |
---|